The value of mental science: we publish what matters.
Malhi GS. et al, (2025), Br J Psychiatry, 1 - 5
Glucagon-Like Peptide 1 Receptor Agonists and Mental Health: A Systematic Review and Meta-Analysis.
Pierret ACS. et al, (2025), JAMA Psychiatry
Glucagon-like peptide-1 receptor agonists for major neurocognitive disorders.
De Giorgi R. et al, (2025), J Neurol Neurosurg Psychiatry
Preliminary evidence should be treated as such: Response to “Is creatine useful as adjuvant in cognitive-behavioural therapy for depression?”
De Giorgi R. et al, (2025), European Neuropsychopharmacology, 93, 15 - 16
Acute angiotensin receptor blockade and mnemonic discrimination in healthy participants.
Prasad D. et al, (2025), J Affect Disord
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
De Giorgi R. et al, (2025), Nature Mental Health
Real-world effects of antidepressants for depressive disorder in primary care: population-based cohort study.
De Crescenzo F. et al, (2024), Br J Psychiatry, 1 - 10
Efficacy and safety profile of oral creatine monohydrate in add-on to cognitive-behavioural therapy in depression: An 8-week pilot, double-blind, randomised, placebo-controlled feasibility and exploratory trial in an under-resourced area.
Sherpa NN. et al, (2024), Eur Neuropsychopharmacol, 90, 28 - 35
Prevalence of Antidepressant Prescriptions for Community-Dwelling Adults Diagnosed with Depressive Disorder in the UK: A Systematic Review
Francia L. et al, (2024), Psychiatric Quarterly
Treatment coverage for depression in the general Spanish population and the impact of the Covid-19 pandemic
Francia L. et al, (2024), Heliyon, 10
Organization of Community Mental Health Care in Italy
De Giorgi S. et al, (2024), Sustainable Development Goals Series, Part F3757, 1 - 10
Setting national research priorities for difficult-to-treat depression in the UK between 2021-2026.
Chapman N. et al, (2022), J Glob Health, 12
An experimental medicine study of the effects of simvastatin on emotional processing, reward learning, verbal memory, and inflammation in healthy volunteers.
De Giorgi R. et al, (2022), Psychopharmacology (Berl)
Effects of various statins on depressive symptoms: is there enough evidence?
De Giorgi R. et al, (2021), Journal of Affective Disorders, 295, 1093 - 1094
Strategies for preventing occupational stress in healthcare workers: Past evidence, current problems
De Giorgi R. and Dinkelaar BM., (2021), BJPsych Advances, 27, 205 - 210
Adjunctive benzodiazepines in depression: A clinical dilemma with no recent answers from research
De Cates AN. and De Giorgi R., (2020), BJPsych Advances, 26, 321 - 326